The Certification Joins Quest's 4 Existing ISO Registrations to Form the Industry's Most Complete Quality Management System IRVINE, CALIFORNIA / ACCESSWIRE / January 9, 2025 / Quest International, the ...
Novo Nordisk A/S and Valo Health, Inc. today announced they have entered into an expanded agreement to discover and develop ...
LOS GATOS, CA / ACCESSWIRE / January 9, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) ...
Exclusive Distributor to Drive International Growth in Chile, Argentina, Peru and Colombia LOS ANGELES, CA / ACCESSWIRE / January 9, 2025 / Med-X, Inc., a leading innovator of all-natural green scene ...
Three customers take delivery at year endVANCOUVER, BC / ACCESSWIRE / January 9, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc," or the "Company"), an innovator in the eHealth ...
LONDON, GB / ACCESSWIRE / January 9, 2025 / Nanomerics Ltd., a private speciality pharmaceutical company today announced that it had completed 28 consecutive days of administration in its OC134 Phase ...
MiscellaneousFormycon included in TecDAX Index of Deutsche Börse 09.01.2025 / 15:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Press Release // January 9, ...
SIOUX FALLS, SD / ACCESSWIRE / January 9, 2025 / Avel eCare, the nation's leading telemedicine provider of clinician-to-clinician services, is proud to announce the acquisition of Amwell Psychiatric ...
New independent directors Christof Bircher and Nneka Ukpai bring significant expertise in business strategy, corporate finance and technology development to Laxxon's Board of Directors. NEW YORK, NY / ...
Alchemab Therapeutics (Alchemab), a biopharmaceutical company aiming to identify and develop naturally occurring therapeutic antibodies from resilient individuals, today announces it has entered a ...
Levels of LDL cholesterol, the so-called ‘bad’ cholesterol that blocks arteries, have been found to be 20% higher immediately after Christmas than during the summer. New research points to a definite ...
Results from the investigational, randomized, open-label IRAKLIA phase 3 study demonstrated that Sarclisa administered at a fixed dose subcutaneously (SC) via an on-body delivery system (OBDS) in ...